Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
775.00 | -49.06% | -28.16% | 697,814.17 | 0.67% | 2.63% |
|
NYSE:ABBV
AbbVie
|
160.45 | -20.2% | -9.65% | 283,333.49 | 3.81% | 7.03% |
|
LSE:AZN
AstraZeneca PLC
|
122.64 | 17.42% | 39.84% | 190,120.82 | 2.04% | 15.98% |
|
SWX:NOVN
Novartis
|
90.54 | 11.53% | 25.32% | 184,738.39 | 3.68% | 4.67% |
|
SWX:ROG
Roche Holding
|
222.30 | 33.69% | 50% | 179,414.05 | 4.34% | 0.43% |
|
NasdaqGS:AMGN
Amgen
|
307.31 | -10.78% | -1.85% | 164,851.75 | 3% | 5.31% |
|
NYSE:PFE
Pfizer
|
28.27 | 9.82% | 40.42% | 160,080.04 | 6.05% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
93.08 | 14.32% | 32.49% | 116,223.94 | 4.09% | 8.19% |
|
NYSE:BMY
Bristol-Myers Squibb
|
43.67 | 63.07% | 73.49% | 88,523.46 | 5.45% | 13.54% |
|
ENXTBR:UCB
UCB
|
121.25 | -38.76% | -10.45% | 23,007.26 | 1.13% | -2.55% |
|
TSE:4503
Astellas Pharma
|
1544.50 | 0% | 0% | 2,769,267.53 | 4.74% | 0% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
15.74 | -44.33% | -40.74% | 17,827.76 | 0% | -2.6% |
|
TSE:4523
Eisai
|
6610.00 | 0% | 0% | 1,895,787.55 | 2.43% | 0% |
|
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
51.20 | 26.09% | 39.4% | 10,538.03 | 2.38% | 10.37% |
|
ENXTPA:IPN
Ipsen
|
116.80 | -12.53% | -4.32% | 9,647.62 | 1.04% | 9.14% |
|
NasdaqGS:ITCI
Intra-Cellular Therapies
|
67.00 | 0% | 0% | 7,073.52 | 0% | 0% |
|
BME:GRF
Grifols
|
9.33 | 256.35% | 364.61% | 5,578.94 | 0% | -19.25% |
|
HLSE:ORNBV
Orion Oyj
|
36.40 | 22.61% | 65.62% | 5,117.58 | 4.49% | -0.43% |
|
NasdaqGS:ALKS
Alkermes
|
24.10 | 175.95% | 200.99% | 4,062.11 | 0% | 18.74% |
|
TSE:4506
Sumitomo Pharma
|
464.00 | 0% | 0% | 396,895 | 0% | 17.88% |
